Literature DB >> 7890408

Expression of endotoxic activities by synthetic monosaccharide lipid A analogs with alkyl-branched acyl substituents.

M Matsuura1, S Shimada, M Kiso, A Hasegawa, M Nakano.   

Abstract

Synthetic monosaccharide lipid A analogs with alkyl-branched acyl substituents instead of the usual ester-branched acyl substituents were investigated for their biological activities. The activities were compared with those of a representative synthetic monosaccharide lipid A analog with an ester branch (GLA-60) and synthetic complete lipid A (506) to estimate the role of the attaching mode of the branched side chains for expression of endotoxic activities. Among the analogs with alkyl branches, GLA-146 and GLA-147, which have C12 and C14 alkyl side chains, respectively, showed strong endotoxic activities. These analogs exhibited comparable or stronger activities than those of GLA-60 in murine macrophage activation activities to induce mediators such as tumor necrosis factors, interleukin 6, and nitric oxide and in mitogenic activity towards murine spleen cells; however, these activities were weaker than the respective activities of 506. With respect to lethal toxicity to galactosamine-sensitized mice, the analogs showed stronger activity than that of GLA-60 and activity closer to that of 506. With respect to adjuvant activity, no significant activity was observed in the analogs, while the activities of GLA-60 and 506 were strong. When lipopolysaccharide-resistant C3H/HeJ mice were used, the activities described above were not observed either for the analogs under investigation nor for GLA-60 and 506. These findings indicate that the ester type of branch in lipid A and its analogs does not play an indispensable role in the expression of various endotoxic activities. However, it may play some role in the expression of adjuvant activity and in lowering the level of toxicity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7890408      PMCID: PMC173173          DOI: 10.1128/iai.63.4.1446-1451.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

Review 1.  The chemical structure of bacterial endotoxin in relation to bioactivity.

Authors:  E T Rietschel; T Kirikae; F U Schade; A J Ulmer; O Holst; H Brade; G Schmidt; U Mamat; H D Grimmecke; S Kusumoto
Journal:  Immunobiology       Date:  1993-04       Impact factor: 3.144

2.  Purification and physico-chemical characterization of rabbit tumor necrosis factor.

Authors:  M R Ruff; G E Gifford
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

3.  Structural requirements of lipid A responsible for the functions: a study with chemically synthesized lipid A and its analogues.

Authors:  J Y Homma; M Matsuura; S Kanegasaki; Y Kawakubo; Y Kojima; N Shibukawa; Y Kumazawa; A Yamamoto; K Tanamoto; T Yasuda
Journal:  J Biochem       Date:  1985-08       Impact factor: 3.387

4.  Multistep regulation mechanisms for tolerance induction to lipopolysaccharide lethality in the tumor-necrosis-factor-alpha-mediated pathway. Application of non-toxic monosaccharide lipid A analogues for elucidation of mechanisms.

Authors:  M Matsuura; M Kiso; A Hasegawa; M Nakano
Journal:  Eur J Biochem       Date:  1994-04-01

5.  Biological activities of chemically synthesized analogues of the nonreducing sugar moiety of lipid A.

Authors:  M Matsuura; Y Kojima; J Y Homma; Y Kubota; A Yamamoto; M Kiso; A Hasegawa
Journal:  FEBS Lett       Date:  1984-02-27       Impact factor: 4.124

6.  Interferon-inducing, pyrogenic and proclotting enzyme of horseshoe crab activation activities of chemically synthesized lipid A analogues.

Authors:  M Matsuura; Y Kojima; J Y Homma; Y Kubota; N Shibukawa; M Shibata; M Inage; S Kusumoto; T Shiba
Journal:  Eur J Biochem       Date:  1983-12-15

7.  Plaque Formation in Agar by Single Antibody-Producing Cells.

Authors:  N K Jerne; A A Nordin
Journal:  Science       Date:  1963-04-26       Impact factor: 47.728

8.  Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages.

Authors:  S D Wright; P S Tobias; R J Ulevitch; R A Ramos
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

9.  Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum.

Authors:  P S Tobias; K Soldau; R J Ulevitch
Journal:  J Exp Med       Date:  1986-09-01       Impact factor: 14.307

10.  Antibody formation by single cells from lymph nodes and efferent lymph of sheep.

Authors:  A J Cunningham; J B Smith; E H Mercer
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

View more
  5 in total

1.  Role of inflammatory mediators in lipid A analogue (ONO-4007)-induced vascular permeability change in mouse skin.

Authors:  H Ishida; E Fujii; K Irie; T Yoshioka; T Muraki; R Ogawa
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

2.  Activity of monosaccharide lipid A analogues in human monocytic cells as agonists or antagonists of bacterial lipopolysaccharide.

Authors:  M Matsuura; M Kiso; A Hasegawa
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

Review 3.  Modulating LPS signal transduction at the LPS receptor complex with synthetic Lipid A analogues.

Authors:  Aileen F B White; Alexei V Demchenko
Journal:  Adv Carbohydr Chem Biochem       Date:  2014       Impact factor: 12.200

4.  Relationship of structure and biological activity of monosaccharide lipid A analogues to induction of nitric oxide production by murine macrophage RAW264.7 cells.

Authors:  K Funatogawa; M Matsuura; M Nakano; M Kiso; A Hasegawa
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

Review 5.  Immunopharmacology of lipid A mimetics.

Authors:  William S Bowen; Siva K Gandhapudi; Joseph P Kolb; Thomas C Mitchell
Journal:  Adv Pharmacol       Date:  2013
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.